Gains_NNS made_VBN by_IN Directors_NNS on_IN share_NN options_NNS and_CC LTIPs_NNS audited_VBD The_DT table_NN below_IN shows_NNS gains_NNS made_VBN by_IN individual_JJ Directors_NNS from_IN the_DT exercise_NN of_IN share_NN options_NNS and_CC LTIPs_NNS ._.
The_DT gains_NNS are_VBP calculated_VBN as_IN at_IN the_DT exercise_NN date_NN ,_, although_IN the_DT shares_NNS may_MD have_VB been_VBN retained_VBN ._.
2002 2001 000 000_CD Dr_NNP John_NNP Brown_NNP 89_CD 330_CD Gordon_NNP Cameron_NNP 585_CD -_: Nicolas_NNP Higgins_NNP 16_CD 343_CD Total_JJ gains_NNS on_IN share_NN options_NNS &_CC LTIPs_NNP 690_CD 673_CD Acambis_NNP Total_NNP Shareholder_NN Return_NN TSR_NNP performance_NN Acambis_NNP TSR_NNP performance_NN is_VBZ shown_VBN against_IN the_DT FTSE_NNP All-Share_NNP Pharmaceuticals_NNP &_CC Biotech_NNP Index_NNP ._.
This_DT index_NN has_VBZ been_VBN chosen_VBN as_IN Acambis_NNP is_VBZ a_DT constituent_NN of_IN this_DT sector_NN ._.
31_CD December_NNP 1997_CD 0_CD On_IN behalf_NN of_IN the_DT Board_NNP Alan_NNP Dalby_NNP ,_, Non-executive_JJ Director_NNP 27_CD March_NNP 2003_CD 63_CD
